Constraints on Publication Rights in Industry-Initiated Clinical Trials

Empirical Evidence for Selective Reporting of Outcomes in Randomized Trials: Comparison of Protocols to Published Articles

Chan, A.-W., Hróbjartsson, A., Haahr, M. T., Gøtzsche, P. C., & Altman, D. G. (2004) · JAMA · doi:10.1001/jama.291.20.2457 · Cited by 1,845 · see citing works

Requisitos uniformes para manuscritos submetidos a periódicos biomédicos: escrevendo e editando para publicações biomédicas

Munhoz, E. (2006) · Epidemiologia e Serviços de Saúde · doi:10.5123/s1679-49742006000100002 · Cited by 417 · see citing works

Principles for international registration of protocol information and results from human trials of health related interventions: Ottawa statement (part 1)

Krleža-Jerić, K., Chan, A., Dickersin, K., Sim, I., Grimshaw, J., & Gluud, C. N. (2005) · BMJ · doi:10.1136/bmj.330.7497.956 · Cited by 236 · see citing works

A national survey of provisions in clinical-trial agreements between medical schools and industry sponsors.

Schulman, K., Seils, D. M., Timbie, J. W., Sugarman, J., Dame, L., Weinfurt, K., Mark, D., & Califf, R. (2002) · New England Journal of Medicine · doi:10.1056/nejmsa020349 · Cited by 176 · see citing works

Academic Medical Centers' Standards for Clinical-Trial Agreements with Industry

Mello, M. M., Clarridge, B. R., & Studdert, D. M. (2005) · New England Journal of Medicine · doi:10.1056/nejmsa044115 · Cited by 132 · see citing works

Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series

(2008) · doi:10.1002/9780470712184 · Cited by 25,048 · see citing works

SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials

Chan, A.-W., Tetzlaff, J. M., Altman, D. G., Laupacis, A., Gøtzsche, P. C., Krleža-Jerić, K., Hróbjartsson, A., Mann, H., Dickersin, K., Berlin, J. A., et al. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-3-201302050-00583 · Cited by 7,363 · see citing works

SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials

Chan, A.-W., Tetzlaff, J. M., Gotzsche, P. C., Altman, D. G., Mann, H., Berlin, J. A., Dickersin, K., Hrobjartsson, A., Schulz, K. F., Parulekar, W. R., et al. (2013) · BMJ · doi:10.1136/bmj.e7586 · Cited by 6,251 · see citing works

Untitled work

(2008) · Cited by 3,790 · see citing works

Conflict of Interest in Medical Research, Education, and Practice

Institute of Medicine (2009) · National Academies Press eBooks · doi:10.17226/12598 · Cited by 824 · see citing works

Reporting bias in medical research - a narrative review

McGauran, N., Wieseler, B., Kreis, J., Schüler, Y.-B., Kölsch, H., & Kaiser, T. (2010) · Trials · doi:10.1186/1745-6215-11-37 · Cited by 452 · see citing works

Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis

Ford, A. C., Talley, N. J., Spiegel, B. M. R., Foxx-Orenstein, A. E., Schiller, L., Quigley, E. M. M., & Moayyedi, P. (2008) · BMJ · doi:10.1136/bmj.a2313 · Cited by 565 · see citing works

Public Availability of Published Research Data in High-Impact Journals

Alsheikh-Ali, A. A., Qureshi, W., Al-Mallah, M. H., & Ioannidis, J. P. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024357 · Cited by 363 · see citing works

Ghost Authorship in Industry-Initiated Randomised Trials

Gøtzsche, P. C., Hróbjartsson, A., Johansen, H. K., Haahr, M. T., Altman, D. G., & Chan, A.-W. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040019 · Cited by 289 · see citing works

Brain aging modulates the neuroprotective effects of estrogen on selective aspects of cognition in women: A critical review

Sherwin, B. B., & Henry, J. F. (2007) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2007.08.002 · Cited by 281 · see citing works

Comparison of protocols and registry entries to published reports for randomised controlled trials

Dwan, K., Altman, D. G., Cresswell, L., Blundell, M., Gamble, C. L., & Williamson, P. R. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.mr000031.pub2 · Cited by 243 · see citing works

SPIRIT 2013 Statement: defining standard protocol items for clinical trials.

Chan, A., Tetzlaff, J., Altman, D. G., Laupacis, A., Gøtzsche, P. C., A-Jerić, K. K., Hrobjartsson, A., Mann, H., Dickersin, K., Berlin, J. A., et al. (2015) · PubMed · Cited by 209 · see citing works

Discrepancies in sample size calculations and data analyses reported in randomised trials: comparison of publications with protocols

Chan, A.-W., Hrobjartsson, A., Jorgensen, K. J., Gotzsche, P. C., & Altman, D. G. (2008) · BMJ · doi:10.1136/bmj.a2299 · Cited by 202 · see citing works

SPIRIT 2025 explanation and elaboration: updated guideline for protocols of randomised trials

Hróbjartsson, A., Boutron, I., Hopewell, S., Moher, D., Schulz, K. F., Collins, G. S., Tunn, R., Aggarwal, R., Berkwits, M., Berlin, J. A., et al. (2025) · BMJ · doi:10.1136/bmj-2024-081660 · Cited by 171 · see citing works

Why we need easy access to all data from all clinical trials and how to accomplish it

Gøtzsche, P. C. (2011) · Trials · doi:10.1186/1745-6215-12-249 · Cited by 137 · see citing works

Sponsorship bias in clinical research

Lexchin, J. (2012) · International Journal of Risk & Safety in Medicine · doi:10.3233/jrs-2012-0574 · Cited by 135 · see citing works

Sharing of clinical trial data among trialists: a cross sectional survey

Rathi, V., Dzara, K., Gross, C. P., Hrynaszkiewicz, I., Joffe, S., Krumholz, H. M., Strait, K. M., & Ross, J. S. (2012) · BMJ · doi:10.1136/bmj.e7570 · Cited by 122 · see citing works

Intravenous alpha-1 antitrypsin augmentation therapy for treating patients with alpha-1 antitrypsin deficiency and lung disease

Gøtzsche, P. C., & Johansen, H. K. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007851.pub3 · Cited by 113 · see citing works

Efficacy and safety of dual SGLT 1/2 inhibitor sotagliflozin in type 1 diabetes: meta-analysis of randomised controlled trials

Musso, G., Gambino, R., Cassader, M., & Paschetta, E. (2019) · BMJ · doi:10.1136/bmj.l1328 · Cited by 94 · see citing works

Best practices in nutrition science to earn and keep the public's trust

Garza, C., Stover, P. J., Ohlhorst, S. D., Field, M. S., Steinbrook, R., Rowe, S. B., Woteki, C. E., & Campbell, E. G. (2019) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqy337 · Cited by 89 · see citing works

Promoting public access to clinical trial protocols: challenges and recommendations

Chan, A.-W., & Hróbjartsson, A. (2018) · Trials · doi:10.1186/s13063-018-2510-1 · Cited by 84 · see citing works

The Financing of Drug Trials by Pharmaceutical Companies and Its Consequences

Schott, G., Pachl, H., Limbach, U., Gundert‐Remy, U., Lieb, K., & Ludwig, W.-D. (2010) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2010.0295 · Cited by 83 · see citing works

Searching ClinicalTrials.gov and the International Clinical Trials Registry Platform to inform systematic reviews: what are the optimal search approaches?

Glanville, J. M., Duffy, S., McCool, R., & Varley, D. (2014) · Journal of the Medical Library Association : JMLA · doi:10.3163/1536-5050.102.3.007 · Cited by 75 · see citing works

Non-steroidal antiandrogen monotherapy compared with luteinising hormone–releasing hormone agonists or surgical castration monotherapy for advanced prostate cancer

Kunath, F., Grobe, H. R., Rücker, G., Motschall, E., Antes, G., Dahm, P., Wullich, B., & Meerpohl, J. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009266.pub2 · Cited by 69 · see citing works

Collaboration between academics and industry in clinical trials: cross sectional study of publications and survey of lead academic authors

Rasmussen, K., Bero, L., Redberg, R., Gøtzsche, P. C., & Lundh, A. (2018) · BMJ · doi:10.1136/bmj.k3654 · Cited by 74 · see citing works

The evolution of assessing bias in Cochrane systematic reviews of interventions: celebrating methodological contributions of the Cochrane Collaboration

Turner, L., Boutron, I., Hróbjartsson, A., Altman, D. G., & Moher, D. (2013) · Systematic Reviews · doi:10.1186/2046-4053-2-79 · Cited by 62 · see citing works

Assessing the risk of ketoacidosis due to sodium-glucose cotransporter (SGLT)-2 inhibitors in patients with type 1 diabetes: A meta-analysis and meta-regression

Musso, G., Sircana, A., Saba, F., Cassader, M., & Gambino, R. (2020) · PLOS Medicine · doi:10.1371/journal.pmed.1003461 · Cited by 61 · see citing works

Publicación de ensayos clínicos en revistas científicas: consideraciones editoriales

Alfonso, F., Segovia, J., Heras, M., & Bermejo, J. (2006) · Revista Española de Cardiología · doi:10.1157/13095794 · Cited by 56 · see citing works

Anti-Caries Effect of Arginine-Containing Formulations in vivo: A Systematic Review and Meta-Analysis

Li, J., Huang, Z., Mei, L., Li, G., & Li, H. (2015) · Caries Research · doi:10.1159/000435894 · Cited by 58 · see citing works

Reporting Bias in Diagnostic and Prognostic Studies: Time for Action

Rifai, N., Altman, D. G., & Bossuyt, P. M. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2008.108993 · Cited by 57 · see citing works

Reporting on blinding in trial protocols and corresponding publications was often inadequate but rarely contradictory

Hróbjartsson, A., Pildal, J., Chan, A.-W., Haahr, M. T., Altman, D. G., & Gøtzsche, P. C. (2009) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2009.04.003 · Cited by 56 · see citing works

Sponsors’ participation in conduct and reporting of industry trials: a descriptive study

Lundh, A., Krogsbøll, L. T., & Gøtzsche, P. C. (2012) · Trials · doi:10.1186/1745-6215-13-146 · Cited by 54 · see citing works

Publication of Clinical Trials in Scientific Journals: Editorial Issves

Alfonso, F., Segovia, J., Heras, M., & Bermejo, J. (2006) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(07)60074-7 · Cited by 51 · see citing works

The occurrence of adverse drug reactions reported for attention deficit hyperactivity disorder (ADHD) medications in the pediatric population: a qualitative review of empirical studies

Aagaard, L., & Hansen, E. H. (2011) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s26403 · Cited by 47 · see citing works

The Geographical Distribution of Leadership in Globalized Clinical Trials

Hoekman, J., Frenken, K., de Zeeuw, D., & Heerspink, H. J. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045984 · Cited by 46 · see citing works

Predictors of clinical trial data sharing: exploratory analysis of a cross-sectional survey

Rathi, V. K., Strait, K. M., Gross, C. P., Hrynaszkiewicz, I., Joffe, S., Krumholz, H. M., Dzara, K., & Ross, J. S. (2014) · Trials · doi:10.1186/1745-6215-15-384 · Cited by 35 · see citing works

Financial Conflicts of Interest Checklist 2010 for clinical research studies.

Rochon, P. A., Hoey, J., Chan, A., Ferris, L. E., Lexchin, J., Kalkar, S. R., Sekeres, M. J., Wu, W., Laethem, M. V., Gruneir, A., et al. (2010) · PubMed Central · Cited by 34 · see citing works

Physician–industry collaboration: Conflicts of interest and the imputation of motive

Wadmann, S. (2014) · Social Studies of Science · doi:10.1177/0306312714525678 · Cited by 34 · see citing works

Agreements between Industry and Academia on Publication Rights: A Retrospective Study of Protocols and Publications of Randomized Clinical Trials

Kasenda, B., von Elm, E., You, J. J., Blümle, A., Tomonaga, Y., Saccilotto, R., Amstutz, A., Bengough, T., Meerpohl, J. J., Stegert, M., et al. (2016) · PLOS Medicine · doi:10.1371/journal.pmed.1002046 · Cited by 33 · see citing works

Influence and management of conflicts of interest in randomised clinical trials: qualitative interview study

Østengaard, L., Lundh, A., Tjørnhøj-Thomsen, T., Abdi, S., Gelle, M. H. A., Stewart, L. A., Boutron, I., & Hróbjartsson, A. (2020) · BMJ · doi:10.1136/bmj.m3764 · Cited by 35 · see citing works

Investigator experiences with financial conflicts of interest in clinical trials

Rochon, P. A., Sekeres, M., Hoey, J., Lexchin, J., Ferris, L. E., Moher, D., Wu, W., Kalkar, S. R., Van Laethem, M., Gruneir, A., et al. (2011) · Trials · doi:10.1186/1745-6215-12-9 · Cited by 31 · see citing works

Access to data in industry-sponsored trials

Lundh, A., Krogsbøll, L. T., & Gøtzsche, P. C. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61871-0 · Cited by 28 · see citing works

A Duty to Participate in Research: Does Social Context Matter?

de Melo‐Martín, I. (2008) · The American Journal of Bioethics · doi:10.1080/15265160802393017 · Cited by 26 · see citing works

Time to all-cause treatment discontinuation of olanzapine compared to other antipsychotics in the treatment of schizophrenia: A systematic review and meta-analysis

Soares‐Weiser, K., Béchard‐Evans, L., Lawson, A. H., Davis, J. M., & Ascher‐Svanum, H. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.05.001 · Cited by 23 · see citing works

Adverse drug reactions associated with asthma medications in children: systematic review of clinical trials

Aagaard, L., & Hansen, E. H. (2014) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-014-9924-y · Cited by 21 · see citing works

Conflict of Interest Policies at Medical Schools and Teaching Hospitals: A Systematic Review of Cross-sectional Studies

Fabbri, A., Hone, K. R., Hróbjartsson, A., & Lundh, A. (2021) · International Journal of Health Policy and Management · doi:10.34172/ijhpm.2021.12 · Cited by 20 · see citing works

Deficiencies in proposed new EU regulation of clinical trials

Gøtzsche, P. C. (2012) · BMJ · doi:10.1136/bmj.e8522 · Cited by 18 · see citing works

Intravenous alpha-1 antitrypsin augmentation therapy for treating patients with alpha-1 antitrypsin deficiency and lung disease

Gøtzsche, P. C., & Johansen, H. K. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007851.pub2 · Cited by 18 · see citing works

SPIRIT 2013 Bildirisi: Klinik Deneyler İçin Standart Protokol Maddelerinin Tanımlanması

Akın, B., & Koçoğlu, D. (2021) · Hacettepe Üniversitesi Hemşirelik Fakültesi Dergisi · doi:10.31125/hunhemsire.908072 · Cited by 17 · see citing works

Therapieempfehlungen der Arzneimittelkommission der deutschen Ärzteschaft

Schott, G., Lasek, R., & Ludwig, W.-D. (2008) · Zeitschrift für Evidenz Fortbildung und Qualität im Gesundheitswesen · doi:10.1016/j.zefq.2008.04.005 · Cited by 17 · see citing works

Rationale and design of repeated cross-sectional studies to evaluate the reporting quality of trial protocols: the Adherence to SPIrit REcommendations (ASPIRE) study and associated projects

Gryaznov, D., Odutayo, A., von Niederhäusern, B., Speich, B., Kasenda, B., Ojeda–Ruiz, E., Blümle, A., Schandelmaier, S., Mertz, D., Tomonaga, Y., et al. (2020) · Trials · doi:10.1186/s13063-020-04808-y · Cited by 15 · see citing works

Commercial funding and estimated intervention effects in randomized clinical trials: Systematic review of meta‐epidemiological studies

Nejstgaard, C. H., Laursen, D. R. T., Lundh, A., & Hróbjartsson, A. (2022) · Research Synthesis Methods · doi:10.1002/jrsm.1611 · Cited by 12 · see citing works

Redactions in protocols for drug trials: what industry sponsors concealed

Marquardsen, M., Ogden, M. C., & Gøtzsche, P. C. (2018) · Journal of the Royal Society of Medicine · doi:10.1177/0141076817750554 · Cited by 11 · see citing works

Industry attack on academics

Gornall, J. (2009) · BMJ · doi:10.1136/bmj.b736 · Cited by 7 · see citing works

Not for your eyes: information concealed through publication bias.

Liesegang, T., Albert, D., & Schachat, A. (2008) · American journal of ophthalmology-glaucoma · doi:10.1016/j.ajo.2008.07.034 · Cited by 4 · see citing works

Commercialism, loss of professionalism, and the effect on journals.

Liesegang, T. (2008) · A M A Archives of Ophthalmology · doi:10.1001/archopht.126.9.1292 · Cited by 4 · see citing works

Start-ups in Science: Entrepreneurs, Diverse Backing, and Novelty Outside Business

Evans, J. A. (2007) · Research in the sociology of organizations · doi:10.1016/s0733-558x(06)25008-0 · Cited by 6 · see citing works

Not enough SPIRIT shown in the registration and reporting of orthodontic trial protocols

Eleftheriadi, I., Ioannou, T., Katechi, V., Seehra, J., & Pandis, N. (2022) · European Journal of Orthodontics · doi:10.1093/ejo/cjac027 · Cited by 5 · see citing works

More Regulation of Industry-Supported Biomedical Research: Are We Asking the Right Questions?

Fry-Revere, S., & Malmstrom, D. (2009) · Journal of Law, Medicine & Ethics · doi:10.1111/j.1748-720x.2009.00403.x · Cited by 3 · see citing works

Sponsor-Imposed Publication Restrictions Disclosed on ClinicalTrials.gov

Stretton, S., Lew, R. A., Ely, J. A., Snape, M. J., Carey, L. C., Haley, C., Woolley, M. J., & Woolley, K. L. (2015) · Accountability in Research · doi:10.1080/08989621.2015.1020375 · Cited by 5 · see citing works

Did relaxing clinical trial regulation enhance the stock of scientific knowledge in India? Not necessarily

Rake, B., & Haeussler, C. (2019) · PLoS ONE · doi:10.1371/journal.pone.0210163 · Cited by 5 · see citing works

Divergent effect of diabetes on fibrosis response to semaglutide and resmetirom in noncirrhotic MASH: A meta-analysis of randomized trials

Musso, G., Pinach, S., Cassader, M., Mariano, F., & Gambino, R. (2026) · Med · doi:10.1016/j.medj.2025.100959 · Cited by 4 · see citing works

Are investigators’ access to trial data and rights to publish restricted and are potential trial participants informed about this? A comparison of trial protocols and informed consent materials

Paludan-Müller, A. S., Ogden, M. C., Marquardsen, M., Jørgensen, K. J., & Gøtzsche, P. C. (2021) · BMC Medical Ethics · doi:10.1186/s12910-021-00681-9 · Cited by 3 · see citing works

Bioethics, Politics and Business

Lötjönen, S., & von Troil, H. (2008) · TemaNord · doi:10.6027/tn2008-570 · Cited by 2 · see citing works

Taking the industry road

Mejia, R. (2008) · Nature · doi:10.1038/nj7198-1138a · Cited by 1 · see citing works

Risks and benefits of face masks in children

Kisielinski, K., Steigleder‐Schweiger, C., Wagner, S., Korupp, S., Hockertz, S., & Hirsch, O. (2026) · Frontiers in Pediatrics · doi:10.3389/fped.2026.1679586 · Cited by 1 · see citing works

Annals of Internal Medicine Research and Reporting Methods

Millum, J., & Menikoff, J. (2010) · Cited by 1 · see citing works

Defining the Intervention Logic of Access-To-Data Measures: A Problem Analysis

Kim, D. (2021) · Munich studies on innovation and competition · doi:10.1007/978-3-030-86778-2_6 · Cited by 1 · see citing works

Industry Influence on Science

Fabbri, A., & Gilmore, A. (2022) · doi:10.1093/oso/9780197578742.003.0008 · Cited by 1 · see citing works

Fiabilidad de los ensayos clínicos aleatorizados publicados

Ruiz, E. M., & Álvarez, J. L. (2008) · Medicina Clínica · doi:10.1157/13128026 · Cited by 1 · see citing works

Intérêts et conflits d’intérêts en nutrition

Martin, A. (2010) · Cahiers de Nutrition et de Diététique · doi:10.1016/j.cnd.2010.01.001 · Cited by 1 · see citing works

Freedom of Science - Can Industry Influence What Scientists Publish?

Ziegler, R., Schnell, O., Kulzer, B., Gilbart, J., & Heinemann, L. (2014) · Europe PMC (PubMed Central) · doi:10.17925/ee.2014.10.01.1 · Cited by 1 · see citing works

Pramlintide for diabetes mellitus

Barbonta, D. H., Loughlan, C. W., Dickerson, J. E. C., & Băicuş, C. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008383.pub2

Conflicts of interest in biomedical publishing

Lundh, A. (2012)

Reviewbias in medical research - a narrative review

McGauran, N., Wieseler, B., Kreis, J., Schüler, Y.-B., Kölsch, H., & Kaiser, T. (2010)

Evaluation of Informed Consent Documents used in Critical Care Trials

Atwere, P. (2015) · uO Research (University of Ottawa) · doi:10.20381/ruor-4033

Intérêts et conflits d’intérêts: le point de vue d’un expert

Martin, A. (2010) · ONCOLOGIE · doi:10.1007/s10269-010-1956-x

Les chercheurs académiques à la croisée de la science industrielle : le cas d’une université japonaise

Carraz, R. (2011) · Serveur des thèses de l'Université de Strasbourg (University of Strasbourg)

Data Governance and Regulation as Critical Foundations for Artificial Intelligence (AI) Implementation in Vascular Diseases

Lareyre, F., & Raffort, J. (2025) · Angiology · doi:10.1177/00033197251395816

SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials

Akın, B., & Koçoğlu, D. (2020) · DergiPark (Istanbul University)

Are investigators’ access to trial data and rights to publish restricted and are potential trial participants informed about this? A comparison of trial protocols and informed consent materials

Paludan-Müller, A. S., Ogden, M. C., Marquardsen, M., Jørgensen, K. J., & Gøtzsche, P. C. (2021) · BMC Medical Ethics · doi:10.1186/s12910-021-00681-9 · Cited by 3 · see citing works

[Registration of clinical trials--results included now!].

Schroeder, T. V. (2008) · PubMed

Data from: Agreements between industry and academia on publication rights: a retrospective study of protocols and publications of randomized clinical trials

Kasenda, B., von Elm, E. B., You, J. J., Blümle, A., Tomonaga, Y., Saccilotto, R. T., Amstutz, A., Bengough, T., Meerpohl, J. J., Stegert, M., et al. (2016) · Data Archiving and Networked Services (DANS) · doi:10.5061/dryad.3s6j7 · Cited by 1 · see citing works

Agreements between Industry and Academia on Publication Rights: A Retrospective Study of Protocols and Publications of Randomized Clinical Trials.

Kasenda, B., von Elm, E. B., You, J. J., Blümle, A., Tomonaga, Y., Saccilotto, R. T., Amstutz, A., Bengough, T., Meerpohl, J. J., Stegert, M., et al. (2016) · Open Access CRIS of the University of Bern · doi:10.7892/boris.94416

Clinical Trial Registration and Publication of Randomized Controlled Trials—Reply

Mathieu, S. (2010) · JAMA · doi:10.1001/jama.2010.96